SE0602550L - Nya formuleringar för behandling av TH2 medierade inflamatoriska sjukdomar - Google Patents

Nya formuleringar för behandling av TH2 medierade inflamatoriska sjukdomar

Info

Publication number
SE0602550L
SE0602550L SE0602550A SE0602550A SE0602550L SE 0602550 L SE0602550 L SE 0602550L SE 0602550 A SE0602550 A SE 0602550A SE 0602550 A SE0602550 A SE 0602550A SE 0602550 L SE0602550 L SE 0602550L
Authority
SE
Sweden
Prior art keywords
treatment
mediated inflammatory
inflammatory diseases
new formulations
inflammatory conditions
Prior art date
Application number
SE0602550A
Other languages
English (en)
Other versions
SE532251C2 (sv
Inventor
Lars Hellman
Original Assignee
Theravac Pharmaceuticals Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravac Pharmaceuticals Ab filed Critical Theravac Pharmaceuticals Ab
Priority to SE0602550A priority Critical patent/SE532251C2/sv
Priority to US12/312,812 priority patent/US20100021486A1/en
Priority to EP07852058A priority patent/EP2099488A4/en
Priority to AU2007326035A priority patent/AU2007326035A1/en
Priority to RU2009119922/15A priority patent/RU2009119922A/ru
Priority to CA002670460A priority patent/CA2670460A1/en
Priority to JP2009538366A priority patent/JP2010510986A/ja
Priority to PCT/SE2007/001037 priority patent/WO2008066444A1/en
Publication of SE0602550L publication Critical patent/SE0602550L/sv
Publication of SE532251C2 publication Critical patent/SE532251C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5418—IL-7
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
SE0602550A 2006-11-28 2006-11-28 Nya formuleringar av TSLP för behandling av TH2-medierade inflammatoriska sjukdomar genom vaccinering SE532251C2 (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE0602550A SE532251C2 (sv) 2006-11-28 2006-11-28 Nya formuleringar av TSLP för behandling av TH2-medierade inflammatoriska sjukdomar genom vaccinering
US12/312,812 US20100021486A1 (en) 2006-11-28 2007-11-26 Tslp vaccine for the treatment of th2 mediated inflammatory conditions
EP07852058A EP2099488A4 (en) 2006-11-28 2007-11-26 TSLP VACCINE FOR THE TREATMENT OF TH2-INDUCED INFLAMMATORY DISORDERS
AU2007326035A AU2007326035A1 (en) 2006-11-28 2007-11-26 TSLP vaccine for the treatment of TH2 mediated inflammatory conditions
RU2009119922/15A RU2009119922A (ru) 2006-11-28 2007-11-26 Вакцина tslp для лечения тн2-опосредованных воспалительных состояний
CA002670460A CA2670460A1 (en) 2006-11-28 2007-11-26 Tslp vaccine for the treatment of th2 mediated inflammatory conditions
JP2009538366A JP2010510986A (ja) 2006-11-28 2007-11-26 Ｔｈ２媒介炎症症状治療のためのｔｓｌｐワクチン
PCT/SE2007/001037 WO2008066444A1 (en) 2006-11-28 2007-11-26 Tslp vaccine for the treatment of th2 mediated inflammatory conditions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0602550A SE532251C2 (sv) 2006-11-28 2006-11-28 Nya formuleringar av TSLP för behandling av TH2-medierade inflammatoriska sjukdomar genom vaccinering

Publications (2)

Publication Number Publication Date
SE0602550L true SE0602550L (sv) 2008-05-29
SE532251C2 SE532251C2 (sv) 2009-11-24

Family

ID=39468148

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0602550A SE532251C2 (sv) 2006-11-28 2006-11-28 Nya formuleringar av TSLP för behandling av TH2-medierade inflammatoriska sjukdomar genom vaccinering

Country Status (8)

Country Link
US (1) US20100021486A1 (sv)
EP (1) EP2099488A4 (sv)
JP (1) JP2010510986A (sv)
AU (1) AU2007326035A1 (sv)
CA (1) CA2670460A1 (sv)
RU (1) RU2009119922A (sv)
SE (1) SE532251C2 (sv)
WO (1) WO2008066444A1 (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8084643B2 (en) 2006-12-13 2011-12-27 Intervet Inc. Water-soluble prodrugs of florfenicol and its analogs
CN102584998B (zh) 2006-12-14 2017-07-04 英特维特国际股份有限公司 犬胸腺基质淋巴细胞生成素蛋白及其应用
US8232372B2 (en) 2006-12-14 2012-07-31 Schering Corp. Engineered anti-TSLP antibody
CA2779384C (en) 2009-11-04 2018-02-27 Schering Corporation Engineered anti-tslp antibody
AR090915A1 (es) 2012-05-04 2014-12-17 Intervet Int Bv Proteina de fusion de proteina linfopoyetina estromal timica canina con la region fc de igg
WO2014162007A2 (en) 2013-04-04 2014-10-09 Ieo - Istituto Europeo Di Oncologia Srl Thymic stromal lymphopoietin fragments and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1129190E (pt) * 1998-11-13 2007-08-08 Immunex Corp Adn e polipéptidos de tslp humanos.
US6890734B2 (en) * 2000-11-10 2005-05-10 Schering Corporation Nucleic acids encoding a cytokine receptor complex
JP5329016B2 (ja) * 2001-07-23 2013-10-30 イミュネックス・コーポレーション 修飾したヒト胸腺ストローマ細胞リンホポエチン
PT1651247E (pt) * 2003-07-18 2008-12-15 Schering Corp Tratamento e diagnóstico de neoplasmas utilizando linfopoietina de estroma tímico
US20050249712A1 (en) * 2004-03-23 2005-11-10 The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health & Human Services Methods for use of TSLP and agonists and antagonists thereof
CA2577631A1 (en) * 2004-08-20 2006-03-02 Amgen Inc. Methods and compositions for treating allergic inflammation

Also Published As

Publication number Publication date
WO2008066444A1 (en) 2008-06-05
US20100021486A1 (en) 2010-01-28
EP2099488A4 (en) 2010-12-22
JP2010510986A (ja) 2010-04-08
AU2007326035A1 (en) 2008-06-05
CA2670460A1 (en) 2008-06-05
SE532251C2 (sv) 2009-11-24
EP2099488A1 (en) 2009-09-16
RU2009119922A (ru) 2011-01-10

Similar Documents

Publication Publication Date Title
CY1121789T1 (el) Νεες ανοσοενισχυτικες συνθεσεις
AR118199A2 (es) Composiciones inmunogénicas de variantes no lipidadas no piruviladas de antígenos orf2086 de neisseria meningitidis, polipéptidos, secuencias de nucleótidos y plásmidos
CY1118691T1 (el) Συνθεσεις και μεθοδοι χρησης για αντισωματα κατα σκληροστινης
AR106768A1 (es) Composiciones que comprenden cepas bacterianas
DK2280721T3 (da) Indoleamin-2, 3-dioxygenasebaseret immunterapi
SE0602550L (sv) Nya formuleringar för behandling av TH2 medierade inflamatoriska sjukdomar
AR060565A1 (es) Vacuna para la gripe aviaria y metodos de uso
ATE523207T1 (de) Stabilisatoren für gefriergetrocknete impfstoffe
AU2015296298A8 (en) Flagellin-based agents and uses including effective vaccination
MX2010004179A (es) Anticuerpos anti-amiloide, composiciones, metodos y usos.
MX2018009945A (es) Composiciones y metodos novedosos para el tratamiento de las enfermedades relacionadas con la inmunidad.
MX341395B (es) Compuestos (lipopeptidos basados en cisteina) y composiciones como agonistas de tlr2 usados para el tratamiento de infecciones, inflamaciones, enfermedades respiratorias, etc.
DK2459216T3 (da) Immunogene sammensætninger omfattende tlr-aktivitetsmodulatorer
IN2012DN02736A (sv)
EA201001639A1 (ru) Композиции и способы их получения и применения
HN2011003011A (es) Composiciones sublinguales de dexmedetomidina y metodos de uso de ellas
BRPI0607551A2 (pt) vacinas de combinação de helicobacter e circovìrus porcino e métodos de uso
BRPI0920240B8 (pt) composição adjuvante
EA201170294A1 (ru) Способы лечения реперфузионных повреждений
EP2574170A4 (en) IMMUNOSTIMULATORY AND VACCINE COMPOSITIONS
WO2014205199A3 (en) Compositions and methods for potentiating immune response, enhancing immunotherapy, and increasing vaccine potency
EA201171001A1 (ru) Пептиды трав для вакцины
WO2009124309A3 (en) Vaccines and immunotherapeutics using il-28 and compositions and methods of using the same
WO2009077577A3 (en) Vaccine antigens from piscirickettsia salmonis
BRPI1012078A2 (pt) construto de proteína, composição imunogênica, molécula de ácido nucleico , métodos de induzir uma resposta imune a casb7439 e de tratar um animal humano ou não-humano, e, uso de uma composição imunogênica